References
- Lister TA, Crowther D, Sutcliffe SB, . Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989;7:1630–1636.
- Levis A, Pietrasanta D, Godio L, . A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma. Clin Lymphoma 2004;5:50–55.
- Howell SJ, Grey M, Chang J, . The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol 2002; 119:408–411.
- Engert A, Eichenauer DA, Dreyling M. Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl. 5):v168–v171.
- Richardson SE, Sudak J, Warbey V, . Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the (18)F-fluoro-2-deoxyglucose positron emission tomography era. Leuk Lymphoma 2012;53: 381–385.
- El-Galaly TC, d'Amore F, Brown PdN, . Routine bone marrow biopsy adds little diagnostic information in patients with newly diagnosed Hodgkin lymphoma undergoing PET/CT staging. Blood 2011;118(Suppl. 1): Abstract 2627.